CUE
#3614
Cue Biopharma, Inc. - Common Stock
27.8 8 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.99%
Monthly Change
+0.58%
6 month change
+10225.93%
Year Change
+3385.00%
Previous Close
28.1 6
Open
27.8 8
Low
27.8 8
High
27.8 8
Volume
8
Financials
- Market Capitalization 202.53 M
- Employee 29
- Founded 2014
- CEO N/A
- Website www.cuebiopharma.com
- Headquarter Delaware, United States
- FIGI BBG00FVMPFN7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.09
Price to sales ratio
1.07
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3596 |  IPHA Innate Pharma S.A. - American Depositary Shares | 2.23 USD | 0.00% | +0.90% | +27.43% | +7.21% | 208.99 M USD | ||
| 3610 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.53 USD | -3.07% | +6.75% | +11.45% | -13.36% | 203.85 M USD | ||
| 3623 |  ACOG Alpha Cognition Inc. - Common Stock | 9.16 USD | -5.95% | -5.76% | +3.97% | +9.96% | 199.49 M USD | ||
| 3625 |  NKTX Nkarta, Inc. - Common Stock | 2.76 USD | +0.36% | +5.34% | +28.97% | +28.37% | 197.68 M USD |
Frequently asked questions about Cue Biopharma, Inc.
What is the Cue Biopharma, Inc. stock price today?
The current price of Cue Biopharma, Inc. (CUE) is 27.88. Over the past 24 hours, the stock has changed by -0.99%. Follow the CUE chart for real-time price dynamics.
What is the stock ticker of Cue Biopharma, Inc.?
Cue Biopharma, Inc. trades under the ticker CUE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cue Biopharma, Inc. stock going up?
CUE has changed by +20.69% over the last week, +0.58% over the last month, and +3385.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Cue Biopharma, Inc.?
Cue Biopharma, Inc. currently has a market capitalization of 202.53 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Cue Biopharma, Inc. earnings last quarter?
Last quarter, Cue Biopharma, Inc. reported earnings of -24.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Cue Biopharma, Inc. revenue for the last quarter?
Cue Biopharma, Inc. reported quarterly revenue of 7.87 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Cue Biopharma, Inc. net income for the last quarter?
Cue Biopharma, Inc. reported net income of -153.07 M for the last quarter. The previous quarter showed -5.18 M, which means net income changed by -2856.10%.
How many employees does Cue Biopharma, Inc. have?
As of the latest available data, Cue Biopharma, Inc. has 29 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cue Biopharma, Inc. EBITDA?
Cue Biopharma, Inc. EBITDA is -87.67 M, and its EBITDA margin is -1 113.66%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cue Biopharma, Inc. stock?
You can buy Cue Biopharma, Inc. (CUE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cue Biopharma, Inc. stock?
Investing in Cue Biopharma, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CUE chart and related analysis on metatrader.com as part of your research.